As such, SIRT1-mTOR-HIF1α signaling coupled with the glycolytic pathway is required for differentiation of Th9 cells and modulation of Th9 cell-associated allergic airway inflammation as well as tumor regression. This evidence concerns the gene HIF1A and neoplasm.